Results 81 to 90 of about 6,571 (189)

Vildagliptin Can Alleviate Endoplasmic Reticulum Stress in the Liver Induced by a High Fat Diet [PDF]

, 2018
Purpose. We investigated whether a DDP-4 inhibitor, vildagliptin, alleviated ER stress induced by a high fat diet and improved hepatic lipid deposition. Methods.
Xiaoqing Ma, Chunxiao Yu, Fei Jing, Wenhua Du, Lingyan Zhou, Shanshan Shao   +5 more
core   +1 more source

Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin

Diabetes, Metabolic Syndrome and Obesity, 2013
Eleonora Russo, Giuseppe Penno, Stefano Del Prato Department of Clinical and Experimental Medicine, Section of Diabetes and Metabolic Disease, Azienda Ospedaliero Universitaria di Pisa, and University of Pisa, Pisa, Italy Background: Dipeptidyl peptidase-
Russo E, Penno G, Del Prato S
doaj  

Myocardial-salvaging Effects of a Novel Polyherbal Combination with Dipeptidyl Peptidase-4 Inhibitory Activity

Nigerian Postgraduate Medical Journal
Background: Some of the medicinal plants possess dipeptidyl peptidase-4 (DPP-4) inhibitory properties and could overcome the limitations of synthetic DPP-4 inhibitors.
Devkumar Durgaprasad Tiwari, Ipseeta Ray Mohanty, Ujwala Maheswari, Prithviraj M. Erande, Vandana M Thorat, Aneesa B. Sayed   +5 more
doaj   +1 more source

EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus

Сахарный диабет, 2013
According to international consensus, metformin is acknowledged as a first-line therapeutic agent for type 2 diabetes mellitus (T2DM). However, in most cases this treatment eventually requires intensification by supplementation with other hypoglycemic ...
Gagik Radikovich Galstyan
doaj   +1 more source

Reduced Weight Gain with Pioglitazone vs Vildagliptin in CREBRF rs373863828 A-allele Carriers: Insights from the WORTH Trial [PDF]

Zanetta LL Toomata,1,2 Yannan Jiang,3,4 Rui Qian Yeu,5 Rebecca Brandon,6 Ry Yves Tweedie-Cullen,1,2 Norma Nehren,7 Glenn Doherty,8 Huti Watson,9 Kerry A Macaskill-Smith,10 Megan Leask,2,11,12 Tony R Merriman,12,13 Ryan Paul,2,14 Troy L Merry,2,15 Peter R
Merry TL, Shepherd PR, Nehren N, Brandon R, Toomata ZLL, Paul R, Watson H, Merriman TR, Jiang Y, Yeu RQ, Macaskill-Smith KA, Leask M, Tweedie-Cullen RY, Doherty G, Murphy R   +14 more
core  

Mild acute pancreatitis with vildagliptin use

Indian Journal of Endocrinology and Metabolism, 2012
Vildagliptin has not been associated with the development of acute pancreatitis in postmarketing reports except one case report from Sydney, Australia.
Ravikant Saraogi, Ritwika Mallik, Sujoy Ghosh   +2 more
doaj   +1 more source

Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes. [PDF]

, 2009
Context: Dipeptidyl peptidase-4 (DPP-4) inhibitors act by increasing plasma levels of glucagon-like peptide-1 (GLP-1) and suppressing excessive glucagon secretion in patients with type 2 diabetes (T2DM). However, their effects on the glucagon response to
Persson, Margaretha,, Nilsson, Peter,, Dejager, Sylvie, Nilsson, Peter, Persson, Margaretha, Lund University., Ahrén, Bo, Dunning, Beth E, Foley, James E, Schweizer, Anja, Ahrén, Bo,   +10 more
core   +1 more source

Potential effect of metformin and vildagliptin against isoniazid induced hepatotoxicity in Wistar albino rats [PDF]

Background: Metformin and vildagliptin both are anti-diabetic agent and they play an important role in diabetic patients as they reduce blood glucose levels.
Kannan A., Rohith, E., Nithyasri, J., Lokesh, M., Narmatha, T., Jeeva, S., Shoba   +5 more
core   +1 more source

Effectiveness and Safety of Vildagliptin Sustained Release in the Management of Type 2 Diabetes Mellitus: Real-World Evidence in Indian Patients [NOVELTY Study]

Drugs - Real World Outcomes
Background and Objective Vildagliptin sustained release (XR), a formulation that provides vildagliptin 100 mg with a once-daily dose administration, is a recent introduction to manage type 2 diabetes mellitus in India.
Rakesh Sahay, Anil Bhansali, Surendra Kumar Sharma, Rahul Iyer, Amarnath Sugumaran, Senthilnathan Mohanasundaram, Jaideep Gogtay   +6 more
doaj   +1 more source

Changes in body weight after 24 weeks of vildagliptin therapy as a function of fasting glucose levels in patients with type 2 diabetes

, 2014
Matthias Blüher,1 Anja Schweizer,2 Giovanni Bader,2 James E Foley3 1Department of Medicine, University of Leipzig, Leipzig, Germany; 2Novartis Pharma AG, Basel, Switzerland; 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA Background ...
Schweizer A, Bader G, Blüher M, Foley JE   +3 more
core